Are we getting closer to a Nobel Prize for unraveling preeclampsia?

Current Cardiology Reports

Volumn 10, Issue 6, 2008, Pages 440-447

  Dechend, Ralf ^b   Luft, Friedrich C ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; AUTOANTIBODY; BEVACIZUMAB; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; PLACENTAL GROWTH FACTOR; PROTEIN ANTIBODY; RELAXIN; RENIN; VASCULOTROPIN;

ARTICLE; AWARDS AND PRIZES; BLOOD VESSEL PERMEABILITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; EARLY DIAGNOSIS; ENDOTHELIAL DYSFUNCTION; FETUS MORTALITY; GENE TARGETING; GESTATIONAL AGE; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HELLP SYNDROME; HEMODYNAMICS; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HUMORAL IMMUNITY; INTRAUTERINE GROWTH RETARDATION; LUNG WEDGE PRESSURE; MALIGNANT HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL RESEARCH; MICROVASCULATURE; NONHUMAN; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PREDICTION; PREECLAMPSIA; PREGNANT WOMAN; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEINURIA; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMALL FOR DATE INFANT; SYSTEMIC VASCULAR RESISTANCE; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULAR ENDOTHELIUM; VASODILATATION;

AMIDOHYDROLASES; FEMALE; HUMANS; MATERNAL MORTALITY; MATERNAL WELFARE; NITRIC OXIDE; PRE-ECLAMPSIA; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1; RELAXIN; RISK ASSESSMENT; RISK FACTORS;

EID: 58249093994     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-008-0070-9     Document Type: Article

References (36)

1. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005, 365:785-799.
2. Poston L, Briley AL, Seed PT, et al.: Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Randomised placebo-controlled trial. Vitamins in Pre-eclampsia (VIP) Trial Consortium. Lancet 2006, 367:1145-1154.
3. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA: Antiplatelet agents for prevention of pre-eclampsia: A meta-analysis of individual patient data. PARIS Collaborative Group. Lancet 2007, 369:1791-1798.
4. Altman D, Carroli G, Duley L, et al.: Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Magpie Trial Collaboration Group. Lancet 2002, 359:1877-1890.
5. Maynard SE, Min JY, Merchan J, et al.: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658.
6. Levine RJ, Maynard SE, Qian C, et al.: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683.
7. Levine RJ, Thadhani R, Qian C, et al.: Urinary placental growth factor and risk of preeclampsia. JAMA 2005, 293:77-85.
8. Venkatesha S, Toporsian M, Lam C, et al.: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 2006, 12:642-649.
9. Levine RJ, Lam C, Qian C, et al.: Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. CPEP Study Group. N Engl J Med 2006, 355:992-1005.
10. Verheul HM, Pinedo HM: Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition. Nat Rev Cancer 2007, 7:475-485.
11. Eremina V, Jefferson JA, Kowalewska J, et al.: VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 2008, 358:1129-1136.
12. Chapman AB, Abraham WT, Zamudio S, et al.: Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998, 54:2056-2063.
13. Groenendijk R, Trimbos JB, Wallenburg HC: Hemodynamic measurements in preeclampsia: Preliminary observations. Am J Obstet Gynecol 1984, 150:232-236.
14. Ma S, Gundlach AL: Relaxin-family peptide and receptor systems in brain: insights from recent anatomical and functional studies. Adv Exp Med Biol 2007, 612:119-137.
15. Jeyabalan A, Shroff SG, Novak J, Conrad KP: The vascular actions of relaxin. Adv Exp Med Biol 2007, 612:65-87.
16. Novak J, Danielson LA, Kerchner LJ, et al.: Relaxin is essential for renal vasodilation during pregnancy in conscious rats. J Clin Invest 2001, 107:1469-1475.
17. Jeyabalan A, Novak J, Danielson LA, et al.: Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration, and reduced myogenic reactivity of small arteries. Circ Res 2003, 93:1249-1257.
18. Carbillon L, Uzan M, Uzan S: Pregnancy, vascular tone, and maternal hemodynamics: A crucial adaptation. Obstet Gynecol Surv 2000, 55:574-581.
19. Savvidou MD, Hingorani AD, Tsikas D, et al.: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003, 361:1511-1517.
20. Wallukat G, Homuth V, Fischer T, et al.: Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999, 103:945-952.
21. Fu ML, Herlitz H, Schulze W, et al.: Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 2000, 18:945-953.
22. Dechend R, Viedt C, Muller DN, et al.: AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation 2003, 107:1632-1639.
23. Bohlender J, Ganten D, Luft FC: Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. J Am Soc Nephrol 2000, 11:2056-2061.
24. Dechend R, Gratze P, Wallukat G, et al.: Agonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsia. Hypertension 2005, 45:742-746.
25. Xia Y, Wen H, Bobst S, et al.: Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells. J Soc Gynecol Investig 2003, 10:82-93.
26. Thway TM, Shlykov SG, Day MC, et al.: Antibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activation. Circulation 2004, 110:1612-1619.
27. Bobst SM, Day MC, Gilstrap LC 3rd, et al.: Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion. Am J Hypertens 2005, 18:330-336.
28. Zhou CC, Ahmad S, Mi T, et al.: Angiotensin II induces soluble fms-like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy. Circ Res 2007, 100:88-95.
29. Zhou CC, Ahmad S, Mi T, et al.: Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 2008, 51:991-992.
30. Hubel CA, Wallukat G, Wolf M, et al.: Agonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsia. Hypertension 2007, 49:612-617.
31. Herse F, Dechend R, Harsem NK, et al.: Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension 2007, 49:604-611.
32. Walther T, Wallukat G, Jank A, et al.: Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension 2005, 46:1275-1279.
33. Stepan H, Faber R, Wessel N, et al.: Relation between circulating angiotensin II type 1 receptor agonistic autoantibodies and soluble fms-like tyrosine kinase 1 in the pathogenesis of preeclampsia. J Clin Endocrinol Metab 2006, 91:2424-2427.
34. Stepan H, Wallukat G, Schultheiss HP, et al.: Is parvovirus B19 the cause for autoimmunity against the angiotensin II type receptor? J Reprod Immunol 2007, 73:130-134.
35. Dragun D, Muller DN, Brasen JH, et al.: Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005, 352:558-569.
36. Zhou CC, Zhang Y, Irani RA, et al.: Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice. Nat Med 2008, 14:855-862.